REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12/06/2025
Back to search
Official data from USPTO
EPISCREEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EPISCREEN
ST13
US500000086716415Class
5, 42, 44
Filing
86716415
Registration
5093688
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
12/07/2025
Trademark type
Word
Nice classes
5, 42, 44
Filing date
08/06/2015
Registration date
12/06/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/30/2023
Last transaction
12/07/2025
Responsible office
United States Patent and Trademark Office
Status code
704
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
24
Owner location
CAMBRIDGE, GB
Examiner
CARROLL,DORITT
Law office
M70
Holders and representatives
Holders
ABZENA (UK) LIMITED
Polytherics Limited
Representatives
Joyce von Natzmer Agris & von Natzmer LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticals and pharmaceutical preparations used to treat cancerdiseases and disorders of the immune systemviral diseases and disordersinflammatory diseasesfibrotic diseasespulmonary diseasesgastro-intestinal diseases and disordershaematological diseases and disordersneurological diseases and disorderspainobesitydiabetes and graft rejection; chemical preparations for medical or pharmaceutical purposeschemicals sold as integral component parts of pharmaceutical preparations for the treatment of cancerdiseases and disorders of the immune systemviral diseases and disordersinflammatory diseasesfibrotic diseasespulmonary diseasesgastro-intestinal diseases and disordershaematological diseases and disordersneurological diseases and disorderspainobesitydiabetes and graft rejection; chemico-pharmaceutical preparationspharmaceutical preparations for the treatment of cancerdiseases and disorders of the immune systemviral diseases and disordersinflammatory diseasesfibrotic diseasespulmonary diseasesgastro-intestinal diseases and disordershaematological diseases and disordersneurological diseases and disorderspainobesitydiabetes and graft rejection; vaccines; pharmaceutical preparations for skin care
Class 42
Scientific research and product development services in relation to pharmaceutical and medical products; pharmaceutical research services; pharmaceutical product evaluation; testing of pharmaceuticalsassessing the potential immunogenicity of proteins and antibodies by measuring immune cell responses to the pharmaceutical; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; provision of scientific information in the fields of cancerdiseases and disorders of the immune systemviral diseases and disordersinflammatory diseasesfibrotic diseasespulmonary diseasesgastro-intestinal diseases and disordershaematological diseases and disordersneurological diseases and disorderspainobesitydiabetes and graft rejection; toxicology services; provision of scientific information relating to the chemical industryinformation on the subject of chemical product development
Class 44
Medical servicesproviding medical information regarding pharmaceuticals; Pharmacy and health advice; pharmaceutical services and provision of pharmaceutical informationall in the nature of providing medical information regarding pharmaceuticals; Medical screening; Medical screening to assess the potential immunogenicity of therapeutic antibodies and proteins
Publications
History of USPTO decisions and trademark events.
30 publications found
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
09/30/2023
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
09/30/2023
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
09/22/2023
PRA8
POST REGISTRATION ACTION MAILED - SEC. 8
06/02/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/02/2023
ES8R
TEAS SECTION 8 RECEIVED
12/02/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/06/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/31/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
12/06/2016
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
10/31/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/30/2016
IUCN
NOTICE OF ALLOWANCE CANCELLED
10/11/2016
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
10/11/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/23/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/28/2016
PUBO
PUBLISHED FOR OPPOSITION
06/28/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/08/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/20/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/13/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/05/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/05/2016
ALIE
ASSIGNED TO LIE
04/28/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/15/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/19/2015
GNRT
NON-FINAL ACTION E-MAILED
11/19/2015
CNRT
NON-FINAL ACTION WRITTEN
11/19/2015
DOCK
ASSIGNED TO EXAMINER
11/18/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/11/2015
NWAP
NEW APPLICATION ENTERED
08/10/2015
Continuous trademark protection
Get notified about every new filing that threatens EPISCREEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.